Principles and Practice of Nephrocardiology
Academic Press Inc (Verlag)
978-0-443-15666-3 (ISBN)
- Noch nicht erschienen (ca. Juni 2024)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
Parta Hatamizadeh, MD, MPH, is an assistant professor of medicine at University of Florida Health in the department of medicine, within the division of nephrology. He is board certified in internal medicine and nephrology. His clinical interests include nephrocardiology, cardiorenal syndrome, acute kidney injury and renal replacement therapy.
Chapter 1: Introduction to Nephrocardiology
Section 1: Heart Failure and pulmonary hypertension
Chapter 2: Introduction to cardiorenal syndrome
Chapter 3: Assessment of volume status
Chapter 4: Optimization of volume
Chapter 5: Approach to the other aspects of cardiorenal syndrome besides hemodynamics
Chapter 6: Combined Heart and Kidney Transplantation
Chapter 7: Cardiogenic Shock
Chapter 8: Nephrocardiologic aspects of pulmonary hypertension
Section 2: Ischemic Heart Disease
Chapter 9: Epidemiology and pathophysiology of Ischemic heart disease in patients with Kidney Disease
Chapter 10: Approach to Ischemic heart disease in the presence of Kidney Disease
Chapter 11: Nephrology related conditions associated with Acute Coronary Syndrome
Section 3: Cardiac Arrhythmias
Chapter 12: Atrial fibrillation
Chapter 13: Sudden cardiac arrest
Section 4: Valvular Heart Diseases
Chapter 14: Valvular heart disease associated with chronic Kidney disease
Chapter 15: Nephrology related conditions associated with valvular heart diseases
Section 5: Congenital Heart Diseases
Chapter 16: Mutual impact of kidney function and various congenital heart diseases
Chapter 17: Electrolyte and acid base abnormalities associated with congenital heart diseases
Section 6: Systemic Hypertension
Chapter 18: Overview of definition, diagnosis, prognosis, and management of hypertension
Chapter 19: Hypertension and kidney diseases
Chapter 20: Hypertension and cardiovascular diseases
Chapter 21: Management of refractory hypertension
Section 7: Vascular Disorders
Chapter 22: Endothelial dysfunction, the heart and the kidneys
Chapter 23: Microangiopathy, the heart and the kidneys
Chapter 24: Atherosclerotic vascular diseases in patients with and without CKD
Chapter 25: Vascular calcification in CKD and uremia
Chapter 26: Renovascular diseases
Section 8: Common Risk Factors in Nephrology and Cardiovascular Medicine
Chapter 27: Diabetes Mellitus
Chapter 28: Dyslipidemia
Chapter 29: Hyperuricemia
Chapter 30: Obesity and kidney
Chapter 31: Obesity and cardiovascular system
Chapter 32: Environmental pollutions
Section 9: Systemic Diseases that Impact Kidney and Cardiovascular System
9.1 Autoimmune Disease
Chapter 33: Systemic Lupus Erythematosus
Chapter 34: Systemic Sclerosis
Chapter 35: Rheumatoid Arthritis
Chapter 36: Antiphospholipid Syndrome
Chapter 37: Psoriasis
9.2 Metabolic Disorders
Chapter 38: Amyloidosis
Chapter 39: Wilson disease
9.3 Ciliopathies
Chapter 40: Autosomal Dominant Polycystic Kidney Disease
Chapter 41: Autosomal Recessive Polycystic Kidney Disease
9.4 Other Ciliopathies
Chapter 42: Medullary sponge kidney, Nephronophthisis, and medullary cystic Kidney disease
9.5 Other Hereditary Disorders
Chapter 43: Fabry’s Disease
Chapter 44: Alport Syndrome
Chapter 45: Marfan Syndrome
9.6 Other Systemic Disorders that involve renal and cardiovascular systems
Chapter 46: Sarcoidosis
Chapter 47: Preeclampsia
Section 10: Chronic Kidney Disease and Cardiovascular System
Chapter 48: Uremic toxins and intestinal microbiota, the kidney and the cardiovascular system
Chapter 49: Mineral metabolism, the kidney and the cardiovascular system
Chapter 50: Anemia, the kidney and the cardiovascular system
Chapter 51: Inflammation and Oxidative Stress, the kidney and the cardiovascular system
Section 11: Cardiovascular interactions with nephrological interventions
Chapter 52: Cardiovascular interactions of hemodialysis
Chapter 53: Cardiovascular interactions of peritoneal dialysis
Chapter 54: Cardiovascular interactions of kidney transplantation
Chapter 55: Nephrology medications with cardiotoxicity and other cardiovascular impact
Section 12: Nephrological interactions with Cardiovascular interventions
Chapter 56: Advanced heart failure devices and cardiac resynchronization therapy
Chapter 57: Cardiac transplantation
Chapter 58: Intravascular contrast material
Chapter 59: Other nephrotoxic drugs and medications with nephrological interactions
Chapter 60: Selection and Dosing of Cardiovascular Medications in the presence of nephrology related conditions
Section 13: Cardiovascular System and Electrolyte and Acid-Base Dysregulations
Chapter 61: Abnormalities of potassium
Chapter 62: Abnormalities of sodium
Chapter 63: Abnormalities of magnesium
Chapter 64: Acid-base dysregulations
Section 14: Other Connections between Nephrology and Cardiovascular Medicine
Chapter 65: Nephrolithiasis and coronary artery disease
Chapter 66: Renal glomerular diseases and cardiovascular diseases
Section 15: New Medications and State of the Art Methos and Technologies
Chapter 67: New hypoglycemic agents
Chapter 68: New mineralocorticoid receptor antagonists
Chapter 69: Point of care ultrasound
Section 18: Future Horizon
Chapter 70: Areas of further studies in nephrocardiology
Chapter 71: The future of Nephrocardiology
| Erscheint lt. Verlag | 1.6.2024 |
|---|---|
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 210 x 295 mm |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
| Medizinische Fachgebiete ► Innere Medizin ► Nephrologie | |
| ISBN-10 | 0-443-15666-2 / 0443156662 |
| ISBN-13 | 978-0-443-15666-3 / 9780443156663 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
